-DOCSTART- -X- O
Vaccination -X- _ O
is -X- _ O
regarded -X- _ O
as -X- _ O
one -X- _ O
of -X- _ O
the -X- _ O
biggest -X- _ O
triumphs -X- _ O
in -X- _ O
the -X- _ O
history -X- _ O
of -X- _ O
medicine. -X- _ O
We -X- _ O
are -X- _ O
living -X- _ O
in -X- _ O
the -X- _ O
most -X- _ O
successful -X- _ O
period -X- _ O
of -X- _ O
vaccine -X- _ O
development. -X- _ O
The -X- _ O
accumulation -X- _ O
of -X- _ O
multidisciplinary -X- _ O
knowledge -X- _ O
and -X- _ O
the -X- _ O
investment -X- _ O
of -X- _ O
massive -X- _ O
funding -X- _ O
have -X- _ O
enabled -X- _ O
the -X- _ O
development -X- _ O
of -X- _ O
vaccines -X- _ O
against -X- _ O
many -X- _ O
infectious -X- _ O
diseases -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
other -X- _ O
diseases -X- _ O
including -X- _ O
malignant -X- _ O
tumors. -X- _ O
The -X- _ O
paradigm -X- _ O
of -X- _ O
clinical -X- _ B-Intervention
vaccine -X- _ I-Intervention
evaluation -X- _ I-Intervention
and -X- _ I-Intervention
licensure -X- _ I-Intervention
has -X- _ O
also -X- _ O
been -X- _ O
modernized -X- _ O
based -X- _ O
on -X- _ O
scientific -X- _ O
improvements -X- _ O
and -X- _ O
historical -X- _ O
experience. -X- _ O
However -X- _ O
, -X- _ O
there -X- _ O
remain -X- _ O
a -X- _ O
number -X- _ O
of -X- _ O
hurdles -X- _ O
to -X- _ O
overcome. -X- _ O
Continuous -X- _ O
efforts -X- _ O
are -X- _ O
focused -X- _ O
on -X- _ O
increasing -X- _ O
the -X- _ O
efficacy -X- _ O
and -X- _ O
reducing -X- _ O
the -X- _ O
risks -X- _ O
related -X- _ O
to -X- _ O
vaccine -X- _ O
use. -X- _ O
Cutting-edge -X- _ B-Outcome
knowledge -X- _ I-Outcome
about -X- _ I-Outcome
immunology -X- _ I-Outcome
and -X- _ I-Outcome
microbiology -X- _ I-Outcome
is -X- _ I-Outcome
being -X- _ I-Outcome
rapidly -X- _ I-Outcome
translated -X- _ I-Outcome
to -X- _ I-Outcome
vaccine -X- _ I-Outcome
development. -X- _ I-Outcome
Thus -X- _ O
, -X- _ O
physicians -X- _ O
and -X- _ O
others -X- _ O
involved -X- _ O
in -X- _ O
the -X- _ O
clinical -X- _ O
development -X- _ O
of -X- _ O
vaccines -X- _ O
should -X- _ O
have -X- _ O
sufficient -X- _ O
understanding -X- _ O
of -X- _ O
the -X- _ O
recent -X- _ O
developmental -X- _ O
trends -X- _ O
in -X- _ O
vaccination -X- _ O
and -X- _ O
the -X- _ O
diseases -X- _ O
of -X- _ O
interest -X- _ O
. -X- _ O

